Tilray Brands Inc TLRY

Hey thanks venture - but I know the assets and liabilities,

[Keeler]

revenue and expense, as well as cash flow of the 5 US MSos I invest in - I'm holding them for US legislation ncluding SAFE, MoRE, the Farm Bill, rescheduling as well as legalization, because if you want to invest in the cannabis sector and are holding law for US legislation, why would you NOT invest in US companies - the ones who will actually benefit from the legislation?
YS MSOs also operate in 40 states that have legalized medical, rec or both - and have done so for years. New legislation or not, there are 6 MSOs with revenues in excess of $1 billion already - what will happen with any new or revised law or if additional states legalize regardless of what the feds do.

Seeing as you know Curaleafs debt - but not Tilrays, Tilray reported tital liabilities of $991.6 million on their Recent financials. They are burning cash - they paid $250 million for Hexo - and saw an increase of only $10 million in Hexos first full quarter - and Tilrays gross profit margin dropped from 51% to 35% - one of the worst margins in cannabis - because they don't know how to control costs.

i can give you numbers on Cannabist, Cresco, Trulieve and Verano in addition to Curaleaf if you like - or you can do your own due diligence -
maybe you'll move your $1200 investment in Medmen to Trulieve if you do. 
I'll be okay without your investment advice - but thanks 'v'

 

 

Comment by Ventura2020on Dec 09, 2023 10:01pm

1 Views 

Post# 35776622

RE:No one cares about Curaleaf Ventura.

You care, Keeler. You own 5 MSO's...apparently. You do not own Tilray.
Im just trying to help you out on some DD. I would hate to see you make a bad investment but, if f you would like some advise, I would buy TilRay Brands and sell those MSO's.
 

What Is Curaleaf Holdings's Net Debt?

Curaleaf Holdings had US$574.1m of debt, at June 2023, which is about the same as the year before. However, because it has a cash reserve of US$85.0m, its net debt is less, at about US$489.1m.

Curaleaf Holdings had liabilities of US$515.9m due within 12 months and liabilities of US$1.48b due beyond that. On the other hand, it had cash of US$85.0m and US$51.0m worth of receivables due within a year. So its liabilities total US$1.86b more than the combination of its cash and short-term receivables.

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. If things get really bad, the lenders can take control of the business. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control.